Geneius Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Geneius General Information

Description

Developer of T-cell therapies intended to cure cancer. The company specializes in the development & commercialization of innovative autologous, adoptive T-cell therapies to make the immune response effective against cancer, enabling patients to become more responsive to multiple tumor-specific antigens that were previously overlooked by their immune systems.

Contact Information

Website
www.geneiusbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Michigan Drive
  • Natick, MA 01760
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 12 Michigan Drive
  • Natick, MA 01760
  • United States
+1 (508)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Clinical Trials - General
3. Later Stage VC 16-Jul-2020 Completed Clinical Trials - General
2. Early Stage VC 12-Sep-2018 $550K $5.94M Completed Clinical Trials - General
1. Seed Round 06-Jan-2016 $5.39M $5.39M Completed Clinical Trials - General
To view Geneius’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Geneius Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Geneius Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3200061-A1 Antigen specific t cells and methods of making and using same Pending 25-Nov-2020
AU-2021388167-A1 Antigen specific t cells and methods of making and using same Pending 25-Nov-2020
US-20240000935-A1 Antigen specific t cells and methods of making and using same Pending 25-Nov-2020
AU-2021388167-A9 Antigen specific t cells and methods of making and using same Pending 25-Nov-2020
EP-4251177-A2 Antigen specific t cells and methods of making and using same Pending 25-Nov-2020 C12N5/0636
To view Geneius’s complete patent history, request access »

Geneius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneius Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority
Impact Assets Impact Investing Minority
Harlem River Navy Family Office Minority
Qral Ventures Venture Capital Minority
To view Geneius’s complete investors history, request access »

Ready to get started?

Request a free trial

Geneius FAQs

  • When was Geneius founded?

    Geneius was founded in 2015.

  • Where is Geneius headquartered?

    Geneius is headquartered in Natick, MA.

  • What is the size of Geneius?

    Geneius has 10 total employees.

  • What industry is Geneius in?

    Geneius’s primary industry is Drug Discovery.

  • Is Geneius a private or public company?

    Geneius is a Private company.

  • What is Geneius’s current revenue?

    The current revenue for Geneius is .

  • How much funding has Geneius raised over time?

    Geneius has raised $5.94M.

  • Who are Geneius’s investors?

    Catalytic Impact Foundation, Impact Assets, Harlem River Navy, and Qral Ventures have invested in Geneius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »